Skip to main content

News

March 29, 2020

DOAC more effective in lowering risk of post-procedure VTE without increasing bleeding risk

WASHINGTON (Mar 29, 2020) - The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous…

March 29, 2020

Subgroup analysis suggests concomitant use of clopidogrel may not play role after PAD revascularizations

WASHINGTON (Mar 29, 2020) - The results of VOYAGER PAD found that people with peripheral artery disease (PAD) who…

March 29, 2020

No increase in the risk of major bleeding seen, including for gastrointestinal cancers

WASHINGTON (Mar 29, 2020) - For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low…

March 16, 2020

March 16, 2020 — As a growing number of medical conferences are being affected by COVID-19, HMP’s CardioVascular Learning Network and Vascular Disease Management are committed to providing enhanced programming to ensure that…

March 05, 2020

SAN CLEMENTE, March 5, 2020 — Reflow Medical, Inc., a California-based medical device company, has announced that they have received clearance from the FDA for an expanded indication for the Wingman™ Crossing Catheter after completing the Wing-IT…

March 04, 2020
Access Vascular, Inc. today announced it has received FDA clearance for the second generation of its HydroPICCTM peripherally inserted central catheter (PICC), which has demonstrated a thrombus accumulation rate 30 times less than traditional PICCs1…
Back to Top